SecBot SecBot
144 ·Filed Nov 5, 2026

ABT

ABBOTT LABORATORIES
NEUTRAL
Impact 2/10
Horizondays Processed11d 5h ago SEC0001783147-26-000011
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for the actual Form 4 filing to see if the sale was executed and at what price. Without the insider's identity and share count, no further action is warranted.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$109.93
T+0 close · Nov 5, 2026 · via day close
Latest settled
−1.28%
T+5 · $108.52
Vs SPY
−3.88%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $109.93entry
  2. T+1 · 8d ago +0.53%α −1.84% · $110.51
  3. T+5 · 4d ago −1.28%α −3.88% · $108.52
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only; document content was unavailable. A Form 144 was filed for Abbott Laboratories on November 5, 2026, indicating an insider's intent to sell restricted or control securities. Without the actual filing content, the identity of the insider, number of shares, and dollar value cannot be determined.

Key Facts

  • Form 144 filed on 2026-11-05 for Abbott Laboratories (ABT)
  • Filing document content was unavailable for analysis
  • Market cap: $189.3B, stock price: $113.61

Financial Impact

Unknown due to unavailable filing content

Risk Factors

  • Filing content unavailable; insider identity and sale size unknown
  • Insider sales can signal lack of confidence but may also be routine diversification

Market Snapshot

Price
$113.61
Volume
125
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (33 analysts)

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

38 reports on ABT

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +17.16% at T+20 after the Jul 1, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 5, 202611d ago 144 Neutral 2/10 Viewing Entry $109.93 Now $107.45 −2.26% settles Dec 7
  2. Oct 27, 202620d ago ANALYST-DOWNGRADE Neutral 2/10 Entry $103.10 Now $107.45 +4.22% settles Nov 24
  3. Oct 27, 202621d ago Court Ruling Neutral 1/10 Entry $102.64 Now $107.45 +4.69% settles Nov 25
  4. Oct 21, 202626d ago Institutional Cluster Mixed 4/10 Entry $102.51 Now $107.45 +4.82% settles Nov 19
  5. Oct 21, 202626d ago 8-K Bullish 6/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
  6. Oct 21, 202626d ago 8-K Bearish 6/10 No price data
  7. Oct 21, 202626d ago Press Release Neutral 4/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
  8. Oct 20, 202628d ago Court Ruling Neutral 1/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
  9. Oct 16, 20264w ago Court Ruling Neutral 2/10 Entry $104.06 to $107.45 Now $107.45 +3.26% ▲ +3.26% +6.72% vs SPY
  10. Oct 15, 20264w ago Court Ruling Bullish 5/10 Entry $104.89 to $108.52 Now $107.45 +2.44% ▲ +3.46% +4.62% vs SPY
Showing 10 of 38

US Market Status

Market Closed · Opens Wed (11h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026